4//SEC Filing
Kurtz Ronald M MD 4
Accession 0000950170-24-083334
CIK 0001111485other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 7:12 PM ET
Size
19.5 KB
Accession
0000950170-24-083334
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Kurtz Ronald M MD
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-07-11−13,500→ 26,836 totalExercise: $15.08Exp: 2030-04-22→ Common Stock (13,500 underlying) - Exercise/Conversion
Common Stock
2024-07-11$15.08/sh+13,500$203,604→ 53,500 total
Holdings
- 764,610(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
- [F2]Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the "2015 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2015 Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. The option originally covered 500,000 shares of common stock pre 10.33 for 1 reverse split shares.
Documents
Issuer
RxSight, Inc.
CIK 0001111485
Entity typeother
Related Parties
1- filerCIK 0001295469
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 7:12 PM ET
- Size
- 19.5 KB